Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases

doi:10.3748/wjg.v22.i42.9300

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 42

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (28972)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

2002

WORD

412

HTML

23360

Figures (1-2)

390

Tables (1-4)

256

Sum=26420

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1095

Download

1457

Sum=2552

Nov 14, 2016 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (165)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Nov 14, 2016; 22(42): 9300-9313
Published online Nov 14, 2016. doi: 10.3748/wjg.v22.i42.9300

Table 4 Prediction of response to anti-tumor necrosis factor therapy - possible biomarkers

Material/method	Predictor for response	Disease	Ref.
Intestinal biopsies	IL1B (upregulated in non-responders)	CD	[54]
Intestinal biopsies	IL17A (upregulated in non-responders)	CD	[54]
Intestinal biopsies	IL13RA2	CD and UC	[16]
	PTGS2
	WNT5A
Blood	high CAI	UC	[17]
	negative ANCA
	IL23R
Blood	High API	CD	[83]
Blood	C-reactive protein	CD and UC	[84]
Intestinal biopsies	TNFRSF11B (osteoprotegerin)	UC	[85]
	STC1 (stanniocalcin-1)
	PTGS2 (prostaglandin-endoperoxide synthase 2)
	IL13Ralpha2 (IL13R alpha 2)
	IL11 (IL-11)
SPECT	High apoptosis rate	CD	[80]
Endoscopic molecular imaging	High mucosal mTNF expression in vivo	CD	[18]

CD: Crohn’s disease; UC: Ulcerative colitis; SPECT: Single-photon emission computer tomography.

Citation: Billmeier U, Dieterich W, Neurath MF, Atreya R. Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases. World J Gastroenterol 2016; 22(42): 9300-9313
URL: https://www.wjgnet.com/1007-9327/full/v22/i42/9300.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i42.9300